Skip to main content
logo
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
2.620
-0.080 (-2.96%)
Oct 30, 2026, 4:00 PM EDT - Market closed

BBOT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23
Market Capitalization
2101,001247-
Market Cap Growth
-77.08%305.70%--
Enterprise Value
-132536--
Last Close Price
2.6212.5210.50-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23
PB Ratio
0.652.441.71-
P/TBV Ratio
0.652.44--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.010.01--
Net Debt / Equity Ratio
-1.06-1.03-1.070.02
Net Debt / EBITDA Ratio
1.722.901.930.00
Net Debt / FCF Ratio
2.253.692.830.01
Quick Ratio
4.3812.157.950.12
Current Ratio
4.6912.348.110.24
Return on Equity (ROE)
-81.92%-48.23%-110.95%-
Return on Assets (ROA)
-47.11%-29.75%-59.37%-
Return on Capital Employed (ROCE)
-61.20%-35.30%-55.90%597.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-97.68%-13.38%-30.09%-
FCF Yield
-72.15%-11.43%-22.31%-
Buyback Yield / Dilution
-12503.20%-241276.23%89.66%-